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Objective: to evaluate pedal bypass grafting in patients with diabetes mellitus with critical limb ischaemia.
Patients and Method: from 1994 to 1999, 49 consecutive pedal bypass grafts were performed in 46 patients with a median
age of 69 years (range 37±85 years). The incidence of insulin-dependent diabetes mellitus was 87%. The distal anastomosis
was located at the dorsalis pedis artery in 36, at the inframalleolar posterior tibial artery in 9 and at the plantar artery in
4 cases, respectively.
Results: one patient died perioperatively. Two bypass occlusions and one major amputation accounted for a primary
patency rate of 96% and a limb salvage rate of 98% at 30 days, respectively. During a median follow-up of 28 months
(range 1±70 months), 21 patients died of nonrelated causes. Three additional graft occlusions and 4 major amputations were
noted resulting in a primary patency rate of 89% and a limb salvage rate of 87% at 48 months, respectively.
Conclusion: Pedal bypass grafting utilising the greater saphenous vein with in-situ technique is a reliable and effective
procedure to achieve durable limb salvage in patients with diabetes mellitus.
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In patients with diabetes mellitus, the prevalence of
gangrene is 20±30 times higher when compared to
non-diabetic patients and the loss of protective sensa-
tion and susceptibility to infection further contribute
to a 10 fold increased risk of amputation when
compared to non-diabetic patients with peripheral
arterial occlusive disease and culminate in the fact
that 40±45% of all amputees are diabetic.1 However,
as patients with long existing diabetes mellitus exhibit
a very distal pattern of arterial occlusive disease,
particularly of tibial vessels with cross-sectional occlu-
sions,2 vascular reconstructive procedures remain
challenging. In this context, pedal bypass grafting
has emerged as a reliable method for durable limb
salvage where limb salvage rates of up to 87% can be
achieved at 5 years3 and current advances in pedal
arterial imaging further facilitate the identification of
reliable target vessels even in difficult situations.4
Autologous vein has clearly proven to be the graft
of choice for infrainguinal arterial revascularisations
in a large recent study of 2650 patients5 and twoPlease address all correspondence to: B. Dorweiler, Department
of Cardiothoracic and Vascular Surgery, University Hospital,
Langenbeckstrasse 1, 55101 Mainz, Germany.
1078±5884/02/04030905 $35.00/0 # 2002 Elsevier Science Ltd. All rprincipal techniques of vein-graft orientation, i.e.
translocated (reversed/non-reversed) and in-situ, are
available. The purpose of the present study was to
evaluate our results of pedal bypass grafting with
autologous vein in a series of diabetic patients with
impending limb loss due to advanced foot lesions.
Patients and Method
At our institution, all patients receiving infrainguinal
reconstructive vascular procedures (bypass grafts)
were prospectively entered into a computer-based
registry (MS ACCESS) and were scheduled for routine
follow-up examinations. In accordance to the purpose
of this study, the vascular surgery registry of our
institution was reviewed for patients with diabetes
mellitus and tissue loss (i.e. gangrene/ulcerations) of
the foot that received pedal arterial bypass grafts
and the retrieved records were analysed. From March
1994 through March 1999, 46 consecutive patients
(10 women, 36 men) with a median age of 69 years
(range 37±85 years) were identified that received
49 pedal bypass grafts with greater saphenous vein.
Three patients were operated bilaterally in staged
procedures. The total number of infrainguinal bypassights reserved.
Table 2. Operative indication and operative details (n 49 limbs).
Operative indication
Gangrene toe/ray 25/7
Ulcerations 19
Inflow source
CFA 5
SFA 11
Popliteal artery AK 8
Popliteal artery BK 25
Distal anastomosis
Dorsalis pedis artery 36
Inframalleolar posterior tibial artery 9
Plantar artery 4
Bypass graft
GSV in situ 40
GSV non-reversed 4
GSV reversed 3
GSV/LSV spliced graft non-reversed 2
Secondary orthopedic procedure
Resection of toe 25
Resection of ray 3
Forefoot amputation 4
CFA common femoral artery, SFA superficial femoral artery,
AK above knee, BK below knee, GSV greater saphenous vein,
LSV lesser saphenous vein.
Table 1. Patient demographics (n 46 patients). ASAAmerican
Society of Anesthesiology.
Median age years (range) 69 (37±85)
Gender: male/female 36/10
Diabetes (insulin-dependent) 46 (40) [100%]
Hypertension 30 [69%]
Hyperlipidaemia 22 [48%]
Coronary artery disease (CAD) 21 [46%]
Chronic renal failure (haemodialysis) 6 [13%]
ASA Class: III/IV 31/15
310 B. Dorweiler et al.procedures performed during that period was 744,
the number of pedal revascularisations 76, respec-
tively. Six pedal bypass grafts were performed in non-
diabetic patients and 21 patients received a sequential
pedal bypass with an additional anastomosis at the
tibial/peroneal artery.
Preoperative diagnostic examinations encompassed
either digital subtraction angiography (DSA), DSA
complemented by a magnetic resonance angiography
(MRA) in selected cases or MRA alone. In addition,
the quality of the greater saphenous vein was assessed
preoperatively by duplex ultrasound examination and
the course of the vein was marked (vein-mapping).
The operations were performed under general
(n 27) or regional (peridural) anaesthesia (n 22)
(the technical details of the operations performed are
outlined in Table 2). For the construction of in-situ
grafts, the greater saphenous vein was prepared
and the side-branches were selectively identified
by gently distending the vein with heparinised saline
while performing stepwise digital occlusion and
ligated. The proximal anastomosis was completed
and subsequently, destruction of vein valves was
performed by a distally inserted catheter mounted
valvulotome (LeMaitre, Vascutech, Burlington MA,
n 21 or in situ cath, Braun, Melsungen, Germany,
n 19). After demonstration of unimpeded blood-
flow, the distal anastomosis was performed. For the
non-reversed grafts (n 4) and the spliced grafts
(n 2), valve destruction was accomplished using
Boehmig-scissors.
Intraoperative flow measurement with an electro-
magnetic flow probe (CM 4008, Cardiomed, Oslo,
Norway) followed by angiography (selective DSA,
MRA) or duplex ultrasound in the early postoperative
period (day 1±3) served as quality control and clinical
and serial duplex ultrasound examinations were rou-
tinely performed at 3, 6 and 12 months postopera-
tively with annual repetitions afterwards.
All patients received intravenous therapeutic anti-
coagulation (unfractionated heparin) in the periopera-
tive period that was replaced by oral anticoagulation
in the majority of cases prior to discharge.
Results
According to the selection criteria in this study, all
patients had diabetes mellitus with a high proportion
being insuline dependent (87%) (Table 1) and all
operations were performed for critical limb ischaemia
with frank tissue loss (Table 2). In addition, resting
pain was present in 19 patients.Eur J Vasc Endovasc Surg Vol 24, October 2002Preoperative angiograms confirmed distal arterial
occlusive disease in all patients with cross-sectional
occlusions of tibial vessels and a patent pedal artery
could be demonstrated in each case by either DSA
or MRA.
The operative time for the procedures ranged from
90 to 300 min with a median of 190 min. Ipsilateral
(n 48) greater saphenous vein with in-situ technique
(n 40) was the predominant graft. In one case, a non-
reversed graft of contralateral greater saphenous vein
was used as preoperative vein-mapping had identi-
fied a non-suitable ipsilateral greater saphenous vein.
Intraoperative flow measurements revealed a median
flow of 40 ml/min (range 10±92 ml/min). One graft
with an intraoperative flow of 4 ml/min developed
subsequent graft thrombosis at postoperative day 1.
Postoperative angiograms (DSA/MRA, n 40) and
duplex ultrasound examinations (n 6) revealed
irregular results in three cases: one bypass compres-
sion, one misplacement of a distal anastomosis (colla-
teral vessel of dorsalis pedis artery) and one stenosis
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Fig. 1. Primary assisted patency (filled squares SE) and limb sal-
vage rate (filled triangles) calculated according to the life-table
method27 for 49 pedal bypass grafts (SE 7.77 at 48 months). The
number of patients at risk at 0, 1, 2, 3 and 4 years is depicted in the
lower part of the diagram.
Pedal Bypass for Limb Salvage in Diabetic Patients 311of a proximal anastomosis that could be revised succ-
essfully. Furthermore, two av-fistulas were detected
that were managed conservatively and occluded
spontaneously as confirmed by subsequent duplex
examination.
There was one death (myocardial infarction)
encountered within 30 days resulting in a periopera-
tive mortality of 2%. Early bypass occlusion occurred
in two cases, both in patients with chronical renal
failure (CRF). Because no reinterventions (thrombect-
omy) were undertaken, this resulted in a cumulative
patency rate of 96%, respectively. One major amputa-
tion had to be performed as a consequence of persist-
ent limb ischaemia after bypass graft thrombosis,
accounting for a limb salvage rate of 98% after 30
days. Minor haematomas were noted in two and sec-
ondary wound healing in four cases, respectively. Of
note, a local advancement flap of full thickness skin
was required in four cases for coverage of the distal
anastomosis to the dorsalis pedis artery. Secondary
orthopedic procedures (minor amputations) were per-
formed in 32 patients with frank tissue loss (gangrene
of toes/rays) as operative indication (Table 2), the
perioperative major amputation was performed in a
patient with ulcerations of the distal calf and foot. The
median follow-up in this series was 28 months (range
1±70 months) and 21 patients died of non-related
cause (cardiac/neoplasm). During that time, four
major amputations and three bypass occlusions were
noted. None of the occluded grafts underwent any
revision (thrombectomy). Two late graft occlusions
(6 and 9 months) remained asymptomatic and one
major amputation had to be performed as a conse-
quence of bypass occlusion 3 months after surgery.
Persistent or recurrent tissue necrosis accounted for
the remaining three amputations that had to be per-
formed despite patent bypass graft (out of them one
patient with lymphoma and immunosupressive medi-
cation and one patient with CRF). The resulting
patency and limb salvage rates are depicted in
Figure 1.
Serial duplex ultrasound examinations led to the
diagnosis of 4 graft stenoses: one significant stenosis
(vmax 300 cm/s) that was confirmed in a DSA was
successfully treated by percutaneous balloon
dilatation (vmax postinterventional 70 cm/s). A second
significant stenosis (vmax 280 cm/s) of a proximal
anastomosis was treated by a patch plasty (vmax post-
interventional 52 cm/s). In one case, a significant
stenosis (vmax 216 cm/s) detected by duplex ultra-
sound turned out to be only of mild degree in a
confirmatory DSA. Retrospectively, it was reasoned
this phenomenon was due to the diameter mismatch
of a wide distal anastomosis to a relatively smallrecipient vessel with extensive calcification. Lastly,
one patient with a distal anastomotic stenosis (vmax
325 cm/s) deceased before a confirmatory DSA could
be scheduled.
The majority of patients (30) was placed on oral anti-
coagulation (phenprocoumon),6 10 patients received
either inhibitors of platelet function (aspirine, n 6)
or fractionated heparine (n 4) due to contra-
indications for oral anticoagulation or chronic haemo-
dialysis, respectively.
Discussion
This study was designed retrospectively to elucidate
the performance of our pedal grafts. A primary
assisted patency rate of 89% and a limb salvage rate
of 87% at 4 years compare favourably with the experi-
ences of other groups.3,7,8
It is noteworthy, that the two early occlusions
occurred in patients with CRF. A reduced expectancy
for graft survival with a patency of 56.1% and a limb
salvage of 73.5% at 3 years was observed in a study
with a similar incidence of CRF (13% of patients).9
Although recent studies have brought a change in
the view of long-term patency results in patients
with CRF, there is consensus that the risk of ampu-
tation despite a patent bypass graft in this group
remains high.7,10,11 In our report, too, one amputation
despite patent bypass graft had to be performed in a
patient with CRF at 48 months. Wound complications
at the site of the distal (pedal) incision have been
observed with a incidence of up to 10%, especially in
diabetic patients of older age (470 years) due
to increasing tension after wound closure and the
tendency to develop postoperative reperfusionEur J Vasc Endovasc Surg Vol 24, October 2002
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created to provide secure and tension free coverage
of the arterial anastomosis while the incision for
venous harvest can be used as donor defect and left
open for secondary healing.13 We also took advantage
of a local advancement flap (full thickness skin) to
cover the distal anastomosis in four cases with and
observed an uneventful wound healing and reepi-
thelisation within two weeks.
Due to the selection criteria in this study, a relevant
tissue defect was present in all patients preoperatively,
therefore, secondary orthopaedic procedures had to
be performed to remove the necrotic tissue. About
two thirds of the minor amputations were performed
in the early postoperative period as soon as demarca-
tion of the necrosis had occurred that in turn enabled a
tissue-sparing amputation at the most distal anatom-
ical level. In all cases with gangrene and impending
septic complications, an open amputation was per-
formed intraoperatively.
We advocate an all autogenous policy for infra-
inguinal, especially pedal revascularisations5 and pre-
operatively, the availability of venous conduits is
examined by duplex ultrasound. Depending on
the morphology, the most suitable vein (greater saphe-
nous vein4 lesser saphenous vein4 cephalic/basilic
vein) is selected and marked. Applying this protocol,
ipsilateral greater spahenous vein served in 48 cases
as conduit, supplemented by lesser saphenous vein in
two cases (spliced grafts). Only in one case, contral-
ateral vein had to be harvested. Interestingly, even in
patients with prior coronary artery bypass procedures
(n 6), ipsilateral vein was available in this study.
Despite contradictionary results from two randomised
studies investigating the utility of duplex scanning for
vein graft surveillance,14,15 current recommendations
strongly emphasise the duplex surveillance of infra-
inguinal vein grafts according to a standardised proto-
col.16,17 The outcome of failed grafts is significantly
worse18 and therefore it is our policy to correct a
failing graft due to a significant stenosis promptly by
a surgical or interventional (balloon angioplasty) pro-
cedure and to follow mild to moderate degree ste-
noses closely. In our study, two out of four stenoses
detected by duplex ultrasound were confirmed to be
critical (high-grade) in a subsequent angiography and
were corrected by a patch/balloon angioplasty.
With regard on the impact of vein graft stenosis,
the utilisation of in-situ saphenous vein for pedal
bypass grafting offers several advantages: the inci-
dence of a de novo graft stenosis was shown to be
significant lower after in-situ grafting.19 Furthermore,
traumatisation of the graft due to dissection and
ischaemia can be minimised while providing anEur J Vasc Endovasc Surg Vol 24, October 2002optimal diameter match and finally, the subcutaneus
course of the graft allows accurate surveillance by
means of duplex ultrasound and easy access in case
of a surgical intervention.
Although several recent prospective studies of
in-situ versus translocated grafts have failed to dem-
onstrate a statistically significant difference in patency
and limb salvage of either technique,20±23 the above
mentioned factors in concert may promote the
improved performance of in-situ grafts for pedal
revascularisation when compared to translocated
grafts.8,24,25
Therefore, the in-situ saphenous vein represents
the conduit of first preference for pedal arterial
reconstructive surgery at our Department.
We noticed an extensive increase in patients with
diabetes mellitus and foot lesions requiring pedal
bypass grafting and two thirds of the 76 pedal bypass
procedures performed between 1994 and 1999 dated
in the last 2 years. Recent reports revealed that
long-term patency, limb salvage and survival rates of
diabetic patients are equal or even superior to non-
diabetic individuals7,26 and based on our results, we
also advocate an aggressive attempt to achieve limb
salvage in this patient subgroup. Currently, the rate of
ankle and pedal revascularisations is approaching
20% of overall infrainguinal bypass procedures. In
this study, as in our institution in general, patient
selection relies primarily to feasibilty of reconstruction
and limb salvage, whereas gender, comorbidity and
age are of secondary influence and a nonambulatory
patient or an advanced tissue defect with non-
salvageable foot (advanced heel/forefoot gangrene)
are the only true contraindications. This is reflected
by the high incidence of patients classified in ASA
category IV (33%) and the median age (69 years) in
this study. In summary, we provided an encouraging
piece of evidence that pedal bypass grafting with
in-situ saphenous vein is a reliable and effective
method for limb salvage in patients with diabetes
mellitus. It is realised that further acquisition of
patients and follow-up is necessary to confirm these
promising results and to extend our knowledge on the
long-term performance of pedal bypass grafting.
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